416 Recruiting Trials

Clinical Trials
for Cancer in Arizona

416 clinical trials for Cancer are currently recruiting participants at study sites in Arizona. Study-related care is provided at no cost.

416
Recruiting trials
269
Study sites
23
Cities
249
Industry-sponsored
149
Phase 2
143
Phase 3

Cancer clinical trials in Arizona: what to expect

Cancer is the single largest area of clinical research, and nearly every recruiting cancer trial is written for one cancer type at one stage. Most test a new drug or combination against the current standard treatment: targeted medicines matched to a mutation found in the tumor, immunotherapies that help the immune system recognize cancer cells, antibody-drug conjugates and cell therapies. Others study surgery and radiation techniques, ways to reduce side effects, and screening or prevention in people at higher risk.

In Arizona, recruiting cancer studies are concentrated in Phoenix, Tucson, Scottsdale and Gilbert, with sites in 19 other cities. 249 of the 416 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who cancer trials usually look for

Every listing names the cancer type and stage it enrolls, and most also state how many earlier treatments you may have had: some are for people newly diagnosed, many are for cancer that has come back or spread after a first treatment stopped working. Targeted-therapy trials require a specific result on tumor testing, which the site can arrange if it has not been done. Trials generally ask that you are well enough for daily activity (a "performance status" the doctor scores), that blood counts and liver and kidney function are adequate, and that a few weeks have passed since your last treatment.

Having advanced or metastatic cancer does not rule you out. A large share of recruiting trials are designed specifically for it.

What taking part involves

Screening reviews your pathology and scans, often with new blood work and sometimes a fresh biopsy. Treatment then follows a cycle, typically every two or three weeks, with scans every six to twelve weeks to measure the response. Early-phase trials have more frequent visits at the start. The study drug and study-specific tests are provided at no cost; standard care that you would receive anyway is usually billed to insurance as normal. A placebo on its own is rare in cancer trials: when there is one, it is added to the standard treatment, and the consent form says so.

Questions worth asking the study team

Whether the trial is randomized and what the comparison treatment is; what happens if the cancer grows during the study; whether you can keep receiving the drug afterward if it is working; how the trial fits with the plan your own oncologist has suggested; and what travel or lodging support is offered. Your oncologist can also refer you directly.

Showing 20 of 416 recruiting Cancer trials in Arizona

Pan Tumor Rollover Study
PHASE2 Tucson, Arizona +4 sites NCT03899155
This trial is looking for patients with cancer who have had a good response to previous treatments. Participants will continue receiving nivolumab alone or in combination with other cancer therapies to study long-term safety.
Recruiting
A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
NA Tucson, Arizona NCT06644560
This trial is looking for American Indian adults diagnosed with cancer who are at least 3 weeks away from their first treatment. Participants will take part in a nutrition and exercise program and provide blood and tissue samples to help measure changes in inflammation levels.
Recruiting
Multi-Cancer Detection Observational Cohort Study
N/A Scottsdale, Arizona +2 sites NCT06962995
This trial is looking for adults who have had or are scheduled for a multi-cancer detection test. Participants will help researchers understand how this test works in real-life healthcare settings.
Recruiting
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
N/A Scottsdale, Arizona +4 sites NCT06008392
This trial is looking for people with a confirmed diagnosis of cancer. Participants will provide samples like blood or tissue to help researchers understand cancer better and improve treatments.
Recruiting
Arizona Cancer Center Biospecimen Repository
N/A Tucson, Arizona NCT00896935
This trial is looking for patients with pancreatic cancer who are being treated at the Arizona Cancer Center or University Medical Center. Participants will provide tissue and blood samples to help with future cancer research.
Recruiting
Multi-Cancer Early Detection (MCED) of Firefighters
N/A Scottsdale, Arizona NCT05780957
This trial is looking for firefighters who are at least 18 years old. Participants will provide blood and urine samples to help test new methods for finding cancer early.
Recruiting
Occupational Exposures Among Firefighters
N/A Scottsdale, Arizona NCT06173843
This trial is looking for current or former firefighters to understand how their work exposures, especially to certain chemicals, might affect their health. Participants will need to provide a sample of blood, urine, or tissue and give consent to join the study.
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3 Tucson, Arizona +4 sites NCT06058377
This trial is looking for women with hormone receptor positive, HER2 negative stage II-III breast cancer. Participants will receive standard chemotherapy along with an immunotherapy drug called durvalumab to see if it helps prevent cancer from coming back.
Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
PHASE3 Phoenix, Arizona +4 sites NCT06510374
This trial is looking for people with intermediate risk non-muscle invasive bladder cancer. Participants will either receive a treatment called Nadofaragene Firadenovec or be monitored without treatment.
Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
PHASE3 Tucson, Arizona +4 sites NCT06545955
This trial is looking for adults with a specific type of bladder cancer called carcinoma in situ (CIS) who have not responded to previous treatments. Participants will receive a treatment called nadofaragene firadenovec, either alone or with other therapies, to see how well it works.
Recruiting
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
PHASE3 Phoenix, Arizona +4 sites NCT06079671
This trial is looking for women with high-risk locally advanced cervical cancer who have not progressed after treatment. Participants will receive volrustomig to see how well it works and what side effects it may cause.
Recruiting
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
PHASE3 Goodyear, Arizona +4 sites NCT06216301
This trial is looking for adults with advanced non-small cell lung cancer that has spread. Participants will receive TTFields, a therapy delivered by a device, along with standard chemotherapy and pembrolizumab, an immune treatment.
Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
PHASE3 Chandler, Arizona +4 sites NCT07291037
This trial is looking for patients with advanced lung cancer that tests positive for a specific protein. Participants will receive either datopotamab deruxtecan or docetaxel as treatment.
Recruiting
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
PHASE3 Scottsdale, Arizona +4 sites NCT07544654
This trial is looking for adults with advanced extrapulmonary neuroendocrine cancer. Participants will receive a study medicine called obrixtamig along with standard chemotherapy and will be monitored for their health over time.
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
PHASE3 Tucson, Arizona +4 sites NCT06561386
This trial is looking for people with advanced non-small cell lung cancer who have not received prior treatment. Participants will compare two different groups of treatment involving chemotherapy and specific medications.
Recruiting
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
PHASE3 Phoenix, Arizona +4 sites NCT07546500
This trial is looking for women aged 18 or older with specific types of ovarian cancer that have not responded to platinum-based treatments. Participants will receive azenosertib or doctor’s choice of chemotherapy to see how well it works.
Recruiting
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
PHASE3 Anchorage, Alaska +4 sites NCT07018869
This trial is looking for people who have recently been diagnosed with stage II or III colorectal cancer and want to improve their follow-up care. Participants will use an educational website with a supportive person in their life to learn about managing their health after cancer treatment.
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
PHASE3 Phoenix, Arizona +4 sites NCT07562152
This trial is looking for adults with advanced pancreatic cancer. Participants will receive a combination treatment to see how effective and safe it is compared to standard treatment.
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
PHASE3 Chandler, Arizona +4 sites NCT06393374
This trial is looking for patients with triple-negative breast cancer who have had surgery but did not have a complete response to previous treatment. If eligible, participants will receive a combination treatment aimed at improving their recovery.
Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
PHASE3 Goodyear, Arizona +4 sites NCT06793215
This trial is looking for adults with advanced lung cancer that has a specific mutation called KRAS G12C. Participants will be comparing two different treatment combinations to see which one works better.
Recruiting

Where the Cancer studies are in Arizona

  • Cancer Center at Saint Joseph's, Phoenix34 trials
  • Mayo Clinic in Arizona, Scottsdale32 trials
  • Mayo Clinic Hospital in Arizona, Phoenix28 trials
  • Banner MD Anderson Cancer Center, Gilbert26 trials
  • Kingman Regional Medical Center, Kingman24 trials
  • Banner University Medical Center - Tucson, Tucson23 trials

Counts are recruiting studies listing at least one site in Arizona, from ClinicalTrials.gov, refreshed every two days.

Cancer clinical trials in Arizona: common questions

How many Cancer clinical trials are recruiting in Arizona?
TrialFinder currently lists 416 recruiting Cancer clinical trials with study sites in Arizona. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Cancer clinical trials located in Arizona?
Study sites for the Cancer trials listed on this page include Tucson, Scottsdale, Phoenix, Goodyear, Chandler. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Cancer clinical trial in Arizona?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Cancer trials in Arizona also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Cancer clinical trial in Arizona?
Each study sets its own criteria based on age, Cancer diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Will I get a placebo instead of cancer treatment?
Almost never. Cancer trials compare a new treatment with the current standard treatment, or add the study drug to standard treatment. When a placebo is used it is on top of standard care, and the consent form states this before you decide.
Can I join a cancer trial if my cancer has spread?
Yes. Many recruiting cancer trials are written for advanced or metastatic disease, including people whose earlier treatments have stopped working. The listing states the stage and prior treatments it accepts.
Do I have to stop my current cancer treatment to join a trial?
It depends on the trial. Some enroll people whose current treatment has stopped working, some add the study drug to the treatment you are on, and some are for people who have not started treatment yet. Ask the study team before changing anything.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Cancer trials near you in Arizona.

Get Matched — Free
No insurance required

Breast cancer trials test new chemotherapy regimens, immunotherapy combinations, targeted therapies, and early-detection methods across all stages of breast cancer.

All Cancer trials →